Exclusive offers, new products and research updates direct to your inbox
It's readily available for cellular use and may be preferable for individuals with certain genetic variations or specific health conditions
Demonstrated that BPC-157 improves insulin signaling and reduces TNF- and IL-6 release in hepatocyte cultures exposed to high-glucose conditions, providing a new model for studying metabolic-dysfunction pathways
That is the whole story, start to finish: a stubborn idea from 1975, a researcher who spent his life on it, a compound that healed everything in rats, a human trial whose result nobody saw for twenty years, a molecule no company can own so no company will finish testing, and a stack of the most basic questions is it safe, at what dose, made by whom, and how does it actually work that still have no answers
Tirzepatide once weekly for the treatment of obesity